Leukemia, Myelogenous, Chronic, BCR-ABL Positive [clinicaltrials_resource:65b591b84e48bdce5f65d37c0dbec1f5]
clinicaltrials:NCT01437202Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan [clinicaltrials:NCT01464411]Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients [clinicaltrials:NCT01511289]Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI [clinicaltrials:NCT01602952]clinicaltrials:NCT01768689Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2) [clinicaltrials:NCT01774630]Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study [clinicaltrials:NCT02389972]clinicaltrials:NCT02421926Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004) [clinicaltrials:NCT02480608]
condition [clinicaltrials_vocabulary:condition]
Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia [clinicaltrials:NCT00001144]The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies [clinicaltrials:NCT00001432]Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002574]Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002592]Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002598]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002674]Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia [clinicaltrials:NCT00002693]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002761]Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002771]Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00002789]Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002800]clinicaltrials:NCT00002832clinicaltrials:NCT00002833Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002868]Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002869]Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00002890]clinicaltrials:NCT00003005Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00003145]Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003230]clinicaltrials:NCT00003239Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003407]Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003561]clinicaltrials:NCT00003693Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase [clinicaltrials:NCT00003694]Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00003727]Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003735]6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003997]R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00004009]Chemotherapy in Treating Patients Who Have Hematologic Cancer [clinicaltrials:NCT00004047]Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00004052]Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia [clinicaltrials:NCT00004181]Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00004878]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia [clinicaltrials:NCT00004905]clinicaltrials:NCT00004933PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [clinicaltrials:NCT00005064]Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia [clinicaltrials:NCT00005618]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00005948]Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00005986]
condition browse [clinicaltrials_vocabulary:condition-browse]
Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia [clinicaltrials:NCT00001144]The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies [clinicaltrials:NCT00001432]Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002574]Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002592]Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002598]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002674]Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia [clinicaltrials:NCT00002693]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002761]Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002771]Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00002789]Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002800]clinicaltrials:NCT00002832clinicaltrials:NCT00002833Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002868]Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002869]Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00002890]clinicaltrials:NCT00003005Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00003145]Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003230]clinicaltrials:NCT00003239Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003407]Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003561]clinicaltrials:NCT00003693Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase [clinicaltrials:NCT00003694]Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00003727]Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003735]6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003997]R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00004009]Chemotherapy in Treating Patients Who Have Hematologic Cancer [clinicaltrials:NCT00004047]Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00004052]Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia [clinicaltrials:NCT00004181]Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00004878]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia [clinicaltrials:NCT00004905]clinicaltrials:NCT00004933PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [clinicaltrials:NCT00005064]Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia [clinicaltrials:NCT00005618]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00005948]Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00005986]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Leukemia, Myelogenous, Chronic, BCR-ABL Positive [clinicaltrials_resource:65b591b84e48bdce5f65d37c0dbec1f5]
Bio2RDF identifier
65b591b84e48bdce5f65d37c0dbec1f5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:65b591b84e48bdce5f65d37c0dbec1f5
identifier
clinicaltrials_resource:65b591b84e48bdce5f65d37c0dbec1f5
title
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
@en
type
label
Leukemia, Myelogenous, Chronic ...... 591b84e48bdce5f65d37c0dbec1f5]
@en
Leukemia, Myelogenous, Chronic, BCR-ABL Positive